Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Evgeny Zaytsev
AddedMar 31, 2024
UpdatedMay 31, 2026
Evgeny Zaytsev

Evgeny Zaytsev

Co-Founder, Bering Capital

CrunchbaseLinkedIn

Evgeny Zaytsev's Career

Bering Capital
Bering Capital
Co-Founder
NovaDigm Therapeutics
NovaDigm Therapeutics

Grand Forks, ND, US

Board Member· Board
Adastra Pharmaceuticals
Adastra Pharmaceuticals

San Diego, CA, US

Board Member· Board
Epic Sciences
Epic Sciences

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Evgeny Zaytsev's Career

Bering Capital
Bering Capital
Investment FirmInvestment Firm22020
Co-Founder

Leadership at Bering Capital

Philip SawyerPhilip SawyerCo-Founder

Similar to Bering Capital

BeringeaBeringeaFarmington Hills, MI, USest. 1988BeringeaFarmington Hills, MI, US · est. 1988

Beringea LLP: A UK-US private equity firm offering investment management and advisory services.

Investment Firm49
Beringer CapitalBeringer CapitalToronto, Ontario, CAest. 1990Beringer CapitalToronto, Ontario, CA · est. 1990

Beringer Capital Inc: A private equity firm specializing in growth investments in North America's ad and marketing industry.

Investment Firm23
Bering Waters VenturesBering Waters VenturesRhode Island, USest. 2019Bering Waters VenturesRhode Island, US · est. 2019

Bering Waters Ventures: A blockchain startup investment firm offering strategic, long-term investments and global resources.

Investment Firm4
CapitalXCapitalXSan Francisco, CA, USest. 2020CapitalXSan Francisco, CA, US · est. 2020

CapitalX, an early-stage venture capital firm, offers high-conviction investments in pre-seed/seed rounds.

Investment Firm9
NovaDigm Therapeutics
NovaDigm Therapeutics
Series A$64.8M302005Grand Forks, ND, US
Board Member· Board

Leadership at NovaDigm Therapeutics

Todd C. BradyTodd C. BradyBoard Member
Fred HaneyFred HaneyBoard Member
Tim CookeTim CookeBoard Member
R. Gordon DouglasR. Gordon DouglasBoard Member
Adastra Pharmaceuticals
Adastra Pharmaceuticals
Acquired$85M02005San Diego, CA, US
Board Member· Board

Leadership at Adastra Pharmaceuticals

Debra K. LiebertDebra K. LiebertBoard Member
Dennis PodlesakDennis PodlesakBoard Member
Ralph ChristoffersenRalph ChristoffersenBoard Member
Chris ChristoffersenChris ChristoffersenBoard Member
Alain SchreiberAlain SchreiberBoard Member
Eckard WeberEckard WeberBoard Member

Similar to Adastra Pharmaceuticals

Adhera TherapeuticsAdhera TherapeuticsDurham, NC, USPharmaceuticalsest. 1983Adhera TherapeuticsDurham, NC, US · est. 1983

US-based Adhera Therapeutics develops specialty pharmaceuticals for inflammatory diseases, hypertension, and cancer.

Seed · $3.2M37
Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Adventris PharmaceuticalsAdventris PharmaceuticalsSan Francisco, CA, USCancer Vaccinesest. 2022Adventris PharmaceuticalsSan Francisco, CA, US · est. 2022

Adventris Pharmaceuticals, a San Francisco-based firm, specializes in developing cancer vaccines.

Pre-Seed · $500k6
Novita PharmaceuticalsNovita PharmaceuticalsNew York City, NY, USCancer Drugsest. 2010Novita PharmaceuticalsNew York City, NY, US · est. 2010

Novita Pharmaceuticals: Developing and providing cancer-treatment drugs since 2010, based in New York.

Series A · $8.5M7
Epic Sciences
Epic Sciences
Series G$219.5M1142008San Diego, CA, US
Board Member· Board

Leadership at Epic Sciences

Greg LucierGreg LucierBoard Member
Dena MarrinucciDena MarrinucciBoard Member
Kim KamdarKim KamdarBoard Member
Richard EglenRichard EglenBoard Member
James RothmanJames RothmanBoard Member
Murali PrahaladMurali PrahaladBoard Member

Similar to Epic Sciences

Epi OneEpi OneNew York City, NY, USCancer Diagnosticsest. 2016Epi OneNew York City, NY, US · est. 2016

Revolutionary cancer diagnosis platform for early prognosis, detection, and drug response.

Series B · $22.9M36
EpinomaEpinomaSan Francisco, CA, USCancer Diagnosticsest. 2020EpinomaSan Francisco, CA, US · est. 2020

Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.

Pre-Seed · $125k6
OnCirc DiagnosticsOnCirc DiagnosticsBeverly Hills, CA, USCancer Diagnosticsest. 2009OnCirc DiagnosticsBeverly Hills, CA, US · est. 2009

Innovative cancer diagnostics biotech in Beverly Hills.

Pre-Seed · $500k30
Exact SciencesExact SciencesMadison, WI, USCancer Diagnosticsest. 1995Exact SciencesMadison, WI, US · est. 1995

Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.

Public · $2.1B6.4k

Evgeny Zaytsev's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Evgeny Zaytsev

Dmitry AkhanovDmitry AkhanovBoard Member · Joule Unlimited TechnologiesYurii UdaltsovYurii UdaltsovBoard Member · Russian Venture CompanyAlex LazovskyAlex LazovskyFounder · West Coast Equity PartnersAnatoly ChubaisAnatoly ChubaisBoard Member · TAE TechnologiesAlexey BasovAlexey BasovBoard Member · Russian Venture CompanyLeonid BoguslavskyLeonid BoguslavskyBoard Member · Rtp-Hc